dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Tabernero Caturla, Josep |
dc.contributor.author | Alsina Maqueda, Maria |
dc.contributor.author | Shitara, Kohei |
dc.contributor.author | Doi, Toshihiko |
dc.contributor.author | Dvorkin, Mikhail |
dc.contributor.author | Mansoor, Wasat |
dc.date.accessioned | 2021-09-20T09:33:47Z |
dc.date.available | 2021-09-20T09:33:47Z |
dc.date.issued | 2020-07 |
dc.identifier.citation | Tabernero J, Alsina M, Shitara K, Doi T, Dvorkin M, Mansoor W, et al. Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS. Gastric Cancer. 2020 Jul;23:689–698. |
dc.identifier.issn | 1436-3305 |
dc.identifier.uri | https://hdl.handle.net/11351/6329 |
dc.description | Càncer gàstric; Qualitat de vida relacionada amb la salut; Trifluridina/tipiracil |
dc.language.iso | eng |
dc.publisher | Springer |
dc.relation.ispartofseries | Gastric Cancer;23 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Estómac - Càncer |
dc.subject | Medicaments antineoplàstics - Ús terapèutic |
dc.subject | Qualitat de vida - Avaluació |
dc.subject.mesh | Stomach Neoplasms |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.subject.mesh | /therapeutic use |
dc.subject.mesh | Quality of Life |
dc.title | Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1007/s10120-020-01053-9 |
dc.subject.decs | neoplasias gástricas |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.subject.decs | /uso terapéutico |
dc.subject.decs | calidad de vida |
dc.relation.publishversion | https://doi.org/10.1007/s10120-020-01053-9 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Tabernero J, Alsina M] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, IOB-Quiron, Barcelona, Spain. [Shitara K, Doi T] National Cancer Center Hospital East, Chiba, Japan. [Dvorkin M] Omsk Regional Clinical Centre of Oncology, Omsk, Russia. [Mansoor W] The Christie NHS Foundation Trust, Manchester, UK |
dc.identifier.pmid | 32128634 |
dc.identifier.wos | 000518419800001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |